Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

Novo Nordisk Pakistan hosted “Unordinary Partnerships to Shape a Healthier Tomorrow” that brought together healthcare ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

A multi-ancestry polygenic risk score could help health care professionals predict a person’s risk for developing obesity ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.

Viking Therapeutics has strong R&D, dual-track obesity drugs, and solid cash runway. Click here to read an analysis of VKTX ...